Jaw Surgery Market Projected to Witness Vigorous Expansion by 2027

 Jaw surgery, also known as orthognathic surgery, is a procedure used to correct a wide range of minor and major skeletal and dental irregularities. It is performed by qualified and skilled oral and maxillofacial surgeons (OMS). Patients with problems related to the jaws, facial asymmetries, and tooth alignment can undergo a jaw surgery. Indications for jaw surgery are maxillary and/or mandibular facial skeletal deformities, speech impairments, chronic jaw or jaw joint pain, facial trauma, and others. It is also used to correct protruding jaw, a congenital defect, or improve the overall facial appearance.

Increasing demand for jaw surgery, extensive use of jaw surgery instruments and devices and technological advancement in healthcare are the major drivers for the growth of the market. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry has also influenced the market growth. Splendid research in the field of cosmetology also boost the market. However, the growth of the market is restrained by unawareness about the advantages of the procedure. Fierce competition among key players in the market restricts the entry of key players.

Additionally, increasing number of maxillary and mandibular surgeries also fuels the growth of the market across the globe.

The global jaw surgery market is expected to grow at a CAGR of 3.7% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5077 

Major Players in the Market:

Some of the key players in the global market are Integra LifeSciences Corporation (U.S.), The Amato Centers for Facial Surgery (U.S.), The Restful Jaw Company, LLC. (U.S.), Millennium Surgical Corp (U.S.), Scanlan International. (U.S.),  Novo Surgical Inc. (U.S.),  HAAG-STREIT GROUP (U.S.), Eurosurgical (U.K),  Sklar Surgical Instruments (U.S.), and others.

Regional Analysis

The market is found to be increasing in the Americas. Increasing number of surgical procedures, and increasing demand for technologically advanced devices for orthognathic procedures are the major drivers for the growth of the market in the U.S. and Canada. Further, concentration of key players manufacturing surgical instruments also fuels the growth of the market.

In Europe, extensive use of technological advanced technologies such as 3D printing for jaw surgeries, and increasing financial support from the government for research and development activities drive the growth of the market. Additionally, increasing number of surgical instrument manufacturers for orthognathic surgery also accelerate the development of the market.

In Asia Pacific, the increasing number of maxillofacial procedures, and rising demand for new technologies also fuel the growth of the market. Additionally, changing lifestyle, and availability of skilled healthcare professionals such as oral and maxillofacial surgeon also marks the development of orthognathic procedures in Asia Pacific. Furthermore, rising awareness about jaw discrepancies and their treatment is also responsible for the growth of the market.

In the Middle East & Africa, rising awareness about orthognathic and orthodontic surgery of treatment of functional deformities related to jaw, teeth, and others. The Middle East acquires the largest market share owing to the availability of specialty healthcare services in the regions such as the United Arab Emirates, and Saudi Arabia. The market shows steady growth in Africa owing to low technological penetration, and increasing demand for primary care services.

Segmentation

The global market is segmented on the basis of instruments, indication, and end user.

On the basis of instruments, market is segmented into curettes, elevators, forceps and needle holders, retractors and speculums, and others.

On the basis of indication, the market is segmented into maxillary and/or mandibular facial skeletal deformities, speech impairments, chronic jaw or jaw joint pain, facial trauma, and others.

On the basis of end user, the market is segmented into hospitals, clinics, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/jaw-surgery-market-5077 

Arteriovenous malformation Market – Functional Survey 2027

 In arteriovenous malformation (AVM), a tangle of blood vessels in the brain or on its surface, bypasses normal brain tissue and directly diverts blood from the arteries to the veins. There are several types of AVM such as true arteriovenous malformation, occult or cryptic AVM or cavernous malformations, and others.

There are various symptoms of arteriovenous malformation which include bleeding in the skull, most commonly a subarachnoid hemorrhage, headaches, focal neurologic deficits such as weakness, numbness, or tingling in one part or side of the body, muscle weakness, inability to move a limb, and lack of coordination. It is estimated that 15 % patients with AVM may have difficulty with movement, speech and vision.

According to the American Stroke Association, AVMs are more common in males than in females, more than 50% of patients with an AVM have intracranial hemorrhage and amongst AVM patients, 20%-25% have focal or generalized seizures.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5092 

The global arteriovenous malformation market is expected to grow at a CAGR of ~6.1% during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global arteriovenous malformation market owing to the presence of huge patient population, high health care spending, and increasing government support for research & development.     

Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating various brain disorders or brain injuries such as epilepsy and depression will have a positive impact on the growth of the market. The growing public awareness will boost the adoption of these devices in the European market.  

Asia Pacific is the fastest growing arteriovenous malformation market across the globe. Japan holds a major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.      

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.  

Segmentation

The global arteriovenous malformation market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of types, it is segmented into true arteriovenous malformation, occult or cryptic AVM or cavernous malformations, venous malformation, hemangioma, and dural fistula. On the basis of diagnosis, it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, Magnetic Resonance Imaging (MRI), magnetic resonance angiography (MRA), and electroencephalography (EEG). On the basis of treatment, the market is segmented into endovascular embolization, neurosurgery and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.

Key Players

Some of key the players in the market are Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/arteriovenous-malformation-market-5092 

Desmoid Tumors Market – Insights on Emerging Scope 2027

 Desmoid tumors are also known as desmoid fibromatosis. These benign growths occur very rarely in the general population. Desmoid tumor usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. The term desmoid was derived from the Greek word desmos, which means tendonlike. Desmoid tumors appear as well-differentiated, and firm overgrowths of fibrous tissue. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States. Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic desmoid tumors.

On molecular level, desmoid tumor is characterized by one of the two mutations in the gene i.e. mutations in the adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During diagnostic procedures CTNNB1 mutation is detected, especially, when pathological differential diagnosis is difficult.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4859 

Rising demand of effective chemotherapeutic agents, high unmet needs of current treatment, and increase in research and development expenditure will promote the growth of desmoid tumors market. According to the Desmoid Rare Foundation, individuals within the age group of 15 and 60 are more likely to get affected. It is also stated that the condition is more prevalent in women than in men (2:1).

High cost of treatment & management of desmoid tumors and related disorders, and lack of infrastructure in middle and low income countries may hamper the growth of the market.

It is estimated that desmoid tumors market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.

Regional Analysis

The Americas dominate the desmoid tumors market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by Centers for Disease Control and Prevention (CDC), it is found that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States. Furthermore, increasing participation of bigger players and new marketers towards advancement in treatment approaches have also attracted a great deal of attention.

Europe holds the second position in the desmoid tumors market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.

Asia Pacific is the fastest growing desmoid tumors market owing to the huge patient pool and developing healthcare technology.

The Middle East & Africa has the lowest market for desmoid tumors market due to lack of technical knowledge and poor medical facilities.

Segmentation

The desmoid tumors market is segmented on the basis of diagnosis, treatment, and end-user.

On the basis of diagnosis, market is segmented into biopsy, electron microscopic examination, immunohistochemical analysis, others

On the basis of treatment, market is classified into surgery, radiation therapy, anti-inflammatory medication, hormone therapy, chemotherapy, novel molecular-targeted therapy, others. Novel molecular-targeted therapy is further segmented into gleevec based therapy, and sorafenib based therapy

On the basis of end-user, market is segmented into hospital, clinics, and others. 

Key Players

Some of key the players in the market are Amgen Inc., Novartis AG, Abbott Laboratories, Bayer AG, AbbVie Inc., Beckman Coulter Inc., Stryker Corporation, Debiopharm Group, F. Hoffmann-La Roche Ltd, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/desmoid-tumors-market-4859 

Lung Function Tests Market: Opportunities and Forecast Assessment, 2020-2027

 Lung function tests, also known as pulmonary function test is used for the diagnosis of lung disorders such as asthma, respiratory infections, chronic obstructive pulmonary disease (COPD), and others. These group of tests also determine the functioning of the lungs, and the ability of a person to breath. They are also a part of tests for routine examination by the healthcare provider. The healthcare provider may recommend lung function tests to diagnose the suspected lung disease, plan the treatment, and decide whether to continue the ongoing treatment or change it and even to stop the treatment if required. Therefore, lung function test plays a vital role in the diagnosis of various respiratory diseases, and lung disorders.

Rising prevalence of lung diseases such as asthma, COPD, and others, availability of lung function test devices, and increasing demand for lung function tests are important factors accelerating the growth of the market. Technological advancements in lung testing and the growing geriatric population are also influencing the market growth. Changing lifestyle, and smoking addiction are leading to a number of lung problems such as lung cancer, which is further driving the growth of the market.

The global lung function tests market is expected to grow at a CAGR of 5.7% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4828 

Major Players in Lung Function Tests Market:

Some of the key players in the global market are CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S., Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others.

Regional Analysis

The lung function tests market is growing at a rapid pace in the Americas owing to emphasis on healthy lifestyle, and prevention of lung diseases. Also, increasing demand for technologically advanced diagnostic devices and the presence of major market players adding fuel to the growth of the market.

In Europe, the prevalence of allergic conditions is high, especially asthma, and allergy rhinitis. Rising prevalence of allergic conditions, and extensive research and development activities on the medical devices drive the market growth.

In Asia Pacific, the increasing prevalence of asthma, chronic obstructive pulmonary disease, poor healthcare system, and availability of diagnostic services leads the market growth. According to the data from GLOBOCAN, in 2012, the age-standardized rate (ASR) of incidence of gastrointestinal diseases in Asia Pacific was 15.8 and mortality was 11.7 per 100,000 person. According to World Health Organization (WHO), the geriatric population in China in the year 2013 was 22.6 million which is expected to show a massive growth to 90.4 million in 2050.

In the Middle East & Africa, the demand for medical devices is increasing for the diagnosis of chronic diseases such as COPD and others. Rising awareness about lung diseases among the adults, and development of the healthcare sector in the African countries also drive the growth of the market.

Segmentation

The global lung function tests market is segmented on the basis of type, indication, devices, and end user.

On the basis of the type, the market is segmented into spirometry, gas diffusion test, body plethysmograph, bronchial provocation test, and others.

On the basis of the indication, the market is segmented into asthma, chronic bronchitis, respiratory infections, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, lung cancer, and others.

On the basis of the devices, the market is segmented into spirometer, breath CO monitor, oscillometer, ergospirometer, dose controlled drug nebulizer, and others.

On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/lung-function-tests-market-4828 

Achondrogenesis Market Detailed Industry Report Analysis 2020-2027

 Achondrogenesis is a severe congential growth hormone deficiency that affects cartilage and bone development. This rare genetic disease is characterized by narrow chest, rounded abdomen, and extremely short limbs. There are majorly three types of achondrogenesis, type 1A, type 1B and type 2. Out of these three, type 1B is most severe and caused by mutations in the SLC26A2 gene. Achondrogenesis type 1B (ACG1B) is also known as Parenti-Fraccaro type. Achondrogenesis exhibits various symptoms such as, abdominal distention, flat face, anteverted nares, frontal bossing, lethal skeletal dysplasia, hydropsfetalis, abnormal enchondral ossification, and many others. According to the U.S National Library of Medicine, the incidence of 1A and 1B, whereas achondrogenesis type 2 occur in 1 in 40,000 to 60,000 newborns. The condition of achondrogenesis type 2 is mostly found in combination with hypochondrogenesis.

Appropriate treatment for the condition is unknown but to deal with the symptoms associated with achondrogenesis, palliative care is suggested by physicians. Genetic Counseling is also recommended to the people who have genetic disorders in their family history. Diagnosis or testing of achondrogenesis is based on histopathologic, clinical, and radiologic features. As per an article published in GeneReviews book, it is found that SLC26A2 is the only mutated gene known to cause ACG1B. Out of all the testing methods, molecular genetic testing is the most commonly used diagnosis for Achondrogenesis Type 1B. Molecular genetic testing method includes targeted mutation analysis, sequence analysis, and deletion/duplication analysis.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4668 

It is estimated that achondrogenesis market is expected to grow at a CAGR 3.9% during the forecast period of 2017-2023. 

Regional Analysis

The Americas dominate the achondrogenesis market owing to the rise in awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention, in 2015, the total health expenditure in the United States was reported as USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Europe holds the second position in achondrogenesis market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.

Asia Pacific is the fastest growing achondrogenesis market owing to the huge patient pool and developing healthcare technology.  

Segmentation

The achondrogenesis market is segmented on the basis of type, diagnosis, and end-users.

On the basis of type, market is segmented into surgery achondrogenesis type IA (Houston-Harris type), achondrogenesis type IA (Houston-Harris type), and achondrogenesis type II (Langer-Saldino type).

On the basis of diagnosis, market is classified into physical examination, molecular genetic testing, and biochemical testing. Physical examination is further classified into X-ray, ultrasound, and others. Molecular genetic testing is also further segmented into Chorionic Villus Sampling (CVS), aminocentesis, and others.

On the basis of end-users, market is segmented into hospital & clinics, diagnostic centers, research & academic institutes, and others.

Key Players

Some of key the players in the achondrogenesis market are Cook, Thermo Fisher Scientific, CooperSurgical Inc., Illumina, Inc., Siemens AG, FUJIFILM Holdings Corporation, Koninklijke, Philips N.V., Stryker, Toshiba Corporation, Invivoscribe, Abbott Molecular Inc., INVITROGEN CORPORATION, Roche Molecular Systems, Inc., and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/achondrogenesis-market-4668 

Corneal Transplant Market Foraying into Emerging Economies 2020-2027

 Corneal transplant is a procedure to replace the damaged or diseased cornea which may be due to eye injury or eye disease. Two major types of corneal transplants are penetrating keratoplasty (full thickness cornea transplant) and endothelial keratoplasty (back layer cornea transplant). Need for corneal transplant may rise if the diseased cornea leads to blurred vision.  According to the World Health Organization (WHO), 285 million people are estimated to be visually impaired worldwide.

The market for corneal transplant shows exponential growth due to high prevalence of corneal eye disease and rising number of corneal transplants in developed countries. High cost of corneal transplants may restrain the market growth. For instance, the cost of corneal transplant is higher in U.S. than other countries in the Asia Pacific.

The global corneal transplant market size is expected to grow at a CAGR of 8.5% during the forecast period 2017 to 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4525 

Major Players in Corneal Transplant Market:

Some of the key players in the global market are CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).

Regional Analysis

Europe is the largest market for corneal transplant which will exhibit positive growth in the near future due to rising prevalence of diabetes in the European countries and availability of treatment options. According to the World Health Organization, about 60 million Europeans have diabetes and its prevalence is relatively high among people over 25 years.

America is the second leading corneal transplant market across the globe owing to an increasing demand for corneal transplant surgery, and rising prevalence of eye diseases, and vision impairment among people in the U.S.

Asia Pacific market is expected to grow rapidly owing increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity. India is one of the international medical tourism destinations across the world, which further exhibits growth opportunities for the corneal transplant market due to availability of cost-effective treatment and rising success rates. Furthermore, the increasing healthcare expenditure by developing countries in Asia Pacific region also contributes to the market growth.

The Middle East & African market is growing steadily owing to rising demand for ophthalmic products and services, and available treatment options.

Segmentation

The global corneal transplant market is segmented on the basis of type, indication, and end user.

On the basis of type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell transplant, and others.

On the basis of indication, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others.

On the basis of end user, the market is segmented into hospitals, eye clinics, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/corneal-transplant-market-4525 

Inguinal Hernia Market – Insights on Emerging Scope 2027

 Inguinal hernia results when a part of small intestine bulges out through a weak area in the lower abdominal wall. Two types of inguinal hernia are known- direct and indirect inguinal hernia.  Direct inguinal hernia occurs in males resulting into the weakening of the abdominal muscles around the inguinal canal. Whereas, indirect inguinal hernia is caused by the defects in the abdominal wall present at the birth. The prevalence of inguinal hernia is found to high in males, which is attributed to stress and increasing age. 

The market for inguinal hernia is expected to show a healthy growth owing to increasing cases of hernia repair and increasing adoption of laparoscopic techniques across the globe. Furthermore, increasing number of hernia repair surgeries also contributes to the progress of the market. Therefore, demand for hernia repair devices is found to be increasing. On the other hand, High cost of the hernia repair devices may act as a restrain for the market growth.

The global inguinal hernia market is expected to grow at a CAGR of 10.8% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4418 

Major Players in Inguinal hernia Market

Some of the key players in the global market are Ethicon, Inc. (U.S.), Medtronic (U.S.), C.R. Bard, Inc. (U.S.), Atrium (U.S.), W.L. Gore & Associates Inc. (U.S.), Acelity (U.S.), and B Braun Melsungen AG (Germany).

Regional Analysis

America is the largest market for inguinal hernia owing to rising prevalence in the U.S. and increasing surgical procedures cases such as groin hernia repair.

Europe is the second largest market owing to increasing prevalence of inguinal hernia and extensive demand for hernia repair devices. The U.K is expected to be the largest market in Europe over the review period.  According to the New England Journal of Medicine, in 2014 more than 90,000 surgical intervention for inguinal hernia were performed in Europe.

In Asia Pacific, rising demand for laparoscopic procedures for inguinal hernia. India is expected to be the largest market in Asia Pacific followed by China and Japan.

The Middle East & Africa also shows a steady rise in the market owing to extensive use of hernia mesh devices for surgeries in the Middle East. In the Middle East, Iran is expected to be the largest market followed by Saudi Arabia. In Africa, high cost of hernia repair restrained the market growth.

Segmentation

The global inguinal hernia market is segmented on the basis of type, diagnosis, treatment and hernia mesh devices.

On the basis of types, market is segmented into direct and indirect hernia. 

On the basis of diagnosis, the market is segmented into physical examination and imaging test. Imaging tests is further segmented into abdominal ultrasound, CT scan and Magnetic Resonance Imaging (MRI).

On the basis of treatment, the market is segmented into open hernia repair, laparoscopy, and others.

On the basis of hernia mesh devices, the market is segmented into synthetic mesh, and biologic mesh.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/inguinal-hernia-market-4418